Skip to main content

Advertisement

ADVERTISEMENT

News

News
09/20/2022
Medtronic announced findings from its Pathological Study of Hypo-Attenuated Leaflet Thickening (HALT) in Self-Expanding Transcatheter Aortic Valves, as part of the CoreValve™ Evolut™ Program.
Medtronic announced findings from its Pathological Study of Hypo-Attenuated Leaflet Thickening (HALT) in Self-Expanding Transcatheter Aortic Valves, as part of the CoreValve™ Evolut™ Program.
Medtronic announced findings...
09/20/2022
Cath Lab Digest
News
09/19/2022
Inari Medical, Inc. announced positive outcomes of the fully enrolled 800-patient FLASH registry in pulmonary embolism (“PE”).
Inari Medical, Inc. announced positive outcomes of the fully enrolled 800-patient FLASH registry in pulmonary embolism (“PE”).
Inari Medical, Inc. announced...
09/19/2022
Cath Lab Digest
News
09/19/2022
Ten-year outcomes after PCI with an everolimus-eluting stent and CABG found no significant difference between the two treatments in terms of safety and major adverse cardiac events.
Ten-year outcomes after PCI with an everolimus-eluting stent and CABG found no significant difference between the two treatments in terms of safety and major adverse cardiac events.
Ten-year outcomes after PCI with...
09/19/2022
Cath Lab Digest
News
09/19/2022
Study findings show that computed tomography cardiac angiography (CTCA) prior to invasive coronary angiography (ICA) in patients who have previously undergone coronary artery bypass grafting (CABG) can reduce the procedural duration and...
Study findings show that computed tomography cardiac angiography (CTCA) prior to invasive coronary angiography (ICA) in patients who have previously undergone coronary artery bypass grafting (CABG) can reduce the procedural duration and...
Study findings show that...
09/19/2022
Cath Lab Digest
News
09/19/2022
New results from the FAVOR III China Trial found that QFR-guided lesion selection for percutaneous coronary intervention (PCI) improved two-year clinical outcomes compared with standard angiography guidance.
New results from the FAVOR III China Trial found that QFR-guided lesion selection for percutaneous coronary intervention (PCI) improved two-year clinical outcomes compared with standard angiography guidance.
New results from the FAVOR III...
09/19/2022
Cath Lab Digest
News
09/19/2022
Results of a three-year, investigator-led study of all Impella-supported patients treated at 109 hospitals in Japan (n=1,344) show 30-day survival rates of 81% for AMI cardiogenic shock (AMICS) patients.
Results of a three-year, investigator-led study of all Impella-supported patients treated at 109 hospitals in Japan (n=1,344) show 30-day survival rates of 81% for AMI cardiogenic shock (AMICS) patients.
Results of a three-year,...
09/19/2022
Cath Lab Digest
News
09/19/2022
Shockwave Medical, Inc., a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, has initiated the first-ever prospective coronary intervention study consisting of all female...
Shockwave Medical, Inc., a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, has initiated the first-ever prospective coronary intervention study consisting of all female...
Shockwave Medical, Inc., a...
09/19/2022
Cath Lab Digest
News
09/18/2022
Furthering evidence for the Intrepid TMVR system, the data offers new clinical insights supporting transapical and transfemoral approaches using the Medtronic Intrepid TMVR System for the treatment of mitral regurgitation (MR).  
Furthering evidence for the Intrepid TMVR system, the data offers new clinical insights supporting transapical and transfemoral approaches using the Medtronic Intrepid TMVR System for the treatment of mitral regurgitation (MR).  
Furthering evidence for the...
09/18/2022
Cath Lab Digest
News
09/18/2022
Findings from the large scale, pivotal, multicenter, sham-controlled RADIANCE II randomized trial found that endovascular ultrasound renal denervation (uRDN) was superior in lowering blood pressure (BP) compared with a sham procedure.
Findings from the large scale, pivotal, multicenter, sham-controlled RADIANCE II randomized trial found that endovascular ultrasound renal denervation (uRDN) was superior in lowering blood pressure (BP) compared with a sham procedure.
Findings from the large scale,...
09/18/2022
Cath Lab Digest
News
09/18/2022
BOSTON – September 18, 2022 – A new sham-controlled clinical evaluation of pulmonary artery denervation (PADN) for patients with pulmonary arterial hypertension (PAH) found that in addition to increasing exercise capacity, PADN improved...
BOSTON – September 18, 2022 – A new sham-controlled clinical evaluation of pulmonary artery denervation (PADN) for patients with pulmonary arterial hypertension (PAH) found that in addition to increasing exercise capacity, PADN improved...
BOSTON – September 18, 2022...
09/18/2022
Cath Lab Digest

Advertisement

Advertisement

Advertisement